SEC Tracker
Get the app

Medicus Pharma MDCX

Medicus Pharma reported financial results

Securities offering

Form
424B3
Filed
Importance
Routine
  1. Cash and cash equivalents of $5,019,755 as of September 30, 2026
  2. Prepaid expenses and other current assets of $1,352,609 as of September 30, 2026
  3. Restricted cash of $8,075,075 as of September 30, 2026

Written from the 424B3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Medicus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Champions Oncology CSBR public float $29M, Oct 31, 2025
  2. OnKure Therapeutics OKUR public float $28M, Jun 30, 2025
  3. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  4. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  5. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.